Hiruma S, Shigiyama F, Kumashiro N. Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with nonalcoholic fatty liver disease: A prospective randomized study. Diabetes Obes Metab 2023 Feb 7. doi: 10.1111/dom.15006.
PMID: 36749298